| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2020165834-A1 | Substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof | 2019-02-15 |
| AU-2020222346-A1 | Substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof | 2019-02-15 |
| CA-3123519-A1 | Substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof | 2019-02-15 |
| AU-2020222346-B2 | Substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof | 2019-02-15 |
| EP-3924055-A1 | Substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof | 2019-02-15 |
| US-2020255403-A1 | 5-alkyl pyrrolidine orexin receptor agonists | 2019-02-13 |
| WO-2020167706-A1 | 5-alkyl pyrrolidine orexin receptor agonists | 2019-02-13 |
| EP-3924058-A1 | 5-alkyl pyrrolidine orexin receptor agonists | 2019-02-13 |
| US-2022017525-A1 | Cyclobutyl pyrazolopyrimidine pde9 inhibitors | 2018-12-12 |
| WO-2020092136-A1 | N-heteroaryl indazole derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof | 2018-10-31 |
